Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Capitol Connections Archive [August 9, 2013] [08.9.13]
Share |

In this Issue

IACP Update on S. 959 

IACP CAMP! What You Can Do to Help Ensure a Positive Outcome on S. 959 Petition Targets IACP Regarding Issue of Compounding for Legal Injections

Domperidone and Boards of Pharmacy: Further Scrutiny?

Harvard Pilgrim: Judge Denies Preliminary Injunction Filed by New England Pharmacies

P2C2 Campaign Designed to Educate Patients and Practitioners About Legislation - Preserving Access to Compounds

Corporate Partner Spotlight: Letco Medical

Events & Education

Join Us for the Next IACP AdvanCE LIVE Webinar on Patient Safety Organizations!

Tara Modisett, Executive Director, Alliance for Patient Medication Safety and Peggy Binzer, JD, Attorney, Polsinelli PC will be presenting Working with a Patient Safety Organization: Improve Quality and Reduce Legal Risk on Thursday, August 22 at 1:00 pm CT (11:00 PT / 12:00 MT / 2:00 ET). In this one-hour webinar you will learn how to align your business strategies with the PSQIA’s objectives of improving quality, enhancing liability protections and reducing dispensing errors.

The Patient Safety and Quality Improvement Act of 2005 (PSQIA or the Act) was passed to create a culture of safety in the practice of medicine, including in pharmacy practice. The Act provides an event reporting shield for medication dispensing errors to remove fear of legal liability, professional sanctions, and injury to professional reputation that prevents pharmacists from sharing information that can improve quality. The Patient Safety Organization (PSO) framework provides an opportunity for pharmacies to participate in continuous quality improvement in a safe environment so that pharmacists can share information about trends and best practices associated with dispensing errors or other medication errors with absolute confidentiality and insulated from discovery and litigation.

At the conclusion of this program, the pharmacist and technician attendee will be able to:

  • Define the Patient Safety and Quality Improvement Act of 2005 (PSQIA).
  • Identify the operational and legal benefits of working with a Patient Safety Organization (PSO).
  • Outline elements of a Continuous Quality Improvement (CQI) program.
  • Describe two Alliance for Patient Medication Safety (APMS) programs that collect and analyze quality-related patient safety data.


This program is made possible through an unrestricted educational grant-in-aid from Fagron.  

Were You Unable to Attend Compounders on Capitol Hill (CCH) 2013?

For the first time, a select few Continuing Education programs from IACP’s 2013 Compounders on Capitol Hill are now available in the IACP AdvanCE self-paced library. If you or members of your staff were unable to join us on-site, don’t feel left out! The IACP AdvanCE self-paced library makes obtaining unique CE convenient for pharmacists and technicians with busy schedules. Take this time to review these sessions and more in the IACP AdvanCE self-paced library, which continues to bring you up-to-date information on legislative, regulatory and practice topics in pharmacy compounding that can affect you and your practice. Click here to view the legislative and marketing CE courses from the conference that are available for immediate access.

IACP AdvanCE Webinar Sponsorship

The IACP AdvanCE Webinar Sponsorship is a unique opportunity for your company as you will not only have exposure to live webinar attendees, but you also will receive future exposure and continued visibility when the live webinar is housed in the self-paced online webinar library. This is a great opportunity to support IACP and demonstrate to its members your commitment to their professional development. Sponsors may choose the webinar topic they’d like to sponsor when multiple live webinars are available. For a detailed listing of the benefits of the IACP AdvanCE Webinar Sponsorship, please click here.

If you would like to discuss the IACP AdvanCE Webinar Sponsorship in greater detail or for a listing of available webinar sponsorships, please email
Michelle Greene or call 281.933.8400.

To receive CE credit, you must submit your NABP e-Profile ID and birth date!

Pharmacists and pharmacy technicians are now required to submit their NABP e-Profile ID to receive credit for any ACPE-accredited CPE session. The new electronic system, CPE Monitor, will now track completed CPE credits online for pharmacists and pharmacy technicians. Please click here to register for your NABP e-Profile ID. You will be asked for your NABP e-Profile ID and date of birth during the registration process to receive CE credit.

It is the responsibility of the CPE attendee to provide their correct NABP e-Profile ID and birth date. If incorrect information is provided, the record will be rejected by CPE Monitor and the CPE credit will not be awarded.

Beginning January 1, 2013, a certificate of attendance is not sufficient to record your CE credit. All credits will be filed electronically on your behalf with NABP’s CPE Monitor.

If you requested Continuing Education credit during registration or at the completion of a program, your CPE credits will be uploaded to the CPE Monitor System within 60 days of completion. If you do not see CPE activity displayed for a session that you attended and it has been more than 60 days since you submitted the CPE to the provider, please contact your CPE provider. If you have any questions regarding IACP continuing education programs, please email
Michelle Greene or call the IACP office at (281) 933-8400.   

USP on Compounding Available from IACP!

IACP is proudly partnering with the United States Pharmacopeial Convention (USP) on their USP on Compounding : A Guide for the Compounding Practitioner, which includes all the compounding-related general chapters from the United States Pharmacopeia–National Formulary (USP–NF). Click here for more information.


August 9, 2013

IACP Update on S. 959  

Revision to S. 959 Secured by IACP: Expressly permits anticipatory compounding for office use

As a result of our continued discussions with the Senate HELP Committee, IACP has succeeded in securing language which clarifies that anticipatory compounding will be permitted within S. 959 as part of the bill’s overall revision of Section 503A of the Federal Drug and Cosmetic Act (FFDCA).

As Section 503A (a)(2)(A) reads now, compounds drug can only be prepared "by a licensed pharmacist or licensed physician in limited quantities before the receipt of a valid prescription order for such individual patient."  Although never enforced, that language does essentially prohibit anticipatory compounding for preparations that are subsequently dispensed or sold to health practitioners for office-use.

Although earlier versions of S. 959 had different language for anticipatory compounding – one of which made it even more stringent and associated with an individual patient – IACP and the Senate HELP Committee have found common ground with new wording.  While S. 959 retains most of the original language of 503A, it now includes an entirely new provision that would - for the very first time - acknowledge and permit anticipatory compounding for office use. Specifically, with respect to a "traditional compounder," the bill provides that "in lieu of the prescription for an identified individual patient... the pharmacy receives a practitioner order." [Page 16, lines 1 - 5].

While that’s a “win” for compounders, there are still so many unworkable provisions within S. 959 that push the scope of federal authority over traditional pharmacy compounding practice well beyond that necessary to prevent a future NECC tragedy.  For example, new requirements for office-use prescriptions mean burdensome recordkeeping provisions for pharmacies including a 10% monthly limit, a 14 day “window” in which the pharmacist must obtain the names of specific patients to whom the medication was administered by the ordering office or practitioner, and a 14-day cap on beyond use dating. 

Please continue to visit IACP's S. 959 Updates section on our website/homepage for continuing news updates from IACP's D.C. legislative team.

NEW: Click here for today's IACP Fax Facts for another update from IACP's legislative team.

NEW: Click here for the latest IACP State Legislation Tracker.

IACP CAMP! What You Can Do to Help Ensure a Positive Outcome on S. 959

The IACP 2013 Summer CAMP (Congressman at My Pharmacy) packet is now available. Click here to access IACP CAMP! It also can be found in the Members-only site - click on Member Resources.

Your IACP CAMP packet includes everything you need to prepare and host a successful congressional visit at your pharmacy. It includes:

  • Instructions for setting up a pharmacy tour with a member of Congress
  • Sample invitation FAX/e-mail to the Senator or Representative's scheduler
  • Sample schedule for the legislator and a sample schedule for your pharmacy team
  • Talking points on pending federal legislation with background explanations to educate yourself and your staff
  • "Day Before" and "Day Of" event instructions
  • A sample thank you letter for follow-up
  • Information on inviting a local media outlet to showcase your visit (pending approval by the legislator)
  • Evaluation form to share your experience with IACP

Please email IACP at with questions! Petition Targets IACP Regarding Issue of Compounding for Legal Injections

IACP Members: Please be aware that a petition was initiated this past week (source of petition unknown) calling for IACP to address the ethics of providing drugs for executions by compounders. Click here to view the petition.

IACP does not take a stance on the use and/or purpose of any medication. That is the responsibility best managed by the individual pharmacist. We support the profession-wide acknowledgement of the rights of the individual pharmacist to engage in informed decision-making based up the professional judgement of the pharmacist, and the prescribing physician.

Please email IACP should you have any questions at

Domperidone and Boards of Pharmacy: Further Scrutiny?

In a July issue of their electronic newsletter, the National Association of Boards of Pharmacy published an article entitled "Domperidone Not FDA Approved, Should Not be Marketed in the US, FDA Stresses." Click here for the NABP article.

The article references the June 2004 FDA warning to compounding pharmacies and suppliers that it is illegal to compound domperidone because the product has never been reviewed or approved for marketing within the US. It also includes information about the access to compounded domperidone for GI motility disorders through the agency's Expanded Access to Investigational Drugs program - click here to view

The FDA requires that domperidone only be obtained from certain specific suppliers and authorization must be approved by them in advance prior to the importation, shipment or administration of the drug. According to the agency, the only authorized supplier of domperidone is Dougherty's Pharmacy in Dallas, Texas.

For compounders, this information is not new. What is concerning about the NABP article is the following statement: "Boards observing that an entity may be obtaining or compounding domperidone under circumstances not in compliance with FDA regulations are encouraged by the agency to report any concerns." IACP members who currently provide compounded domperidone to patients and prescribers should be aware that Board inspectors may be following this federal policy during inspections and should contact their Boards to determine whether or not the state has a different interpretation or position than that of the FDA.  

For additional information on the FDA position, pharmacists may direct any questions to the FDA Division of Drug Information by sending an e-mail to or by calling (855) 543-3784.  

Harvard Pilgrim Update: Judge Denies Preliminary Injunction Filed by New England Pharmacies

The preliminary injunction filed by three pharmacies in New England against Harvard Pilgrim, alleging that a change in their reimbursement/coverage of compounded medications was damaging to beneficiaries, has been denied by the judge.  Click here for a copy of the decision, provided by IACP's counsel.

Click here for a Boston Globe editorial, "More Nuanced Rules Needed at Harvard Pilgrim," August 6, 2013.

IACP Members: Please note that IACP prepared an amicus brief for this case which was excluded by the judge. We are holding it for now as this case may continue to proceed and, unfortunately, we may need it for other cases against third-party plans seeking to reduce or eliminate coverage of compounded medications.

Unhappy Patients Voice Displeasure on Harvard Pilgrim's Facebook Page

While the Harvard Pilgrim situation continues to swirl, the company's Facebook page is the target of many unhappy customers who are not pleased that their compounded meds will no longer be covered. Click here to visit Harvard Pilgrim's Facebook site. The company states: Many of you have questions and comments about our recent decision to discontinue coverage of compound medications. Our goal is to provide our members and providers with access to a wide variety of safe and effective medications. If you and your physician feel a compound medication is medically necessary, your physician may submit to our review process on your behalf. Harvard Pilgrim will review your request within one business day. We encourage you to contact our Member Services team with any questions via our secure message portal here or by calling 1-888-333-4742.

For those IACP members with patients being affected by this situation, be sure to send them to Harvard Pilgrim's message portals noted above to voice their opinions. IACP will continue to keep you apprised of this situation. Please email with any questions.

My Health. My Compounds - P2C2 Campaign Designed to Educate Patients and Practitioners About Legislation - Preserving Access to Compounds

IACP's Patients and Professionals for Customized Care (P2C2) advocacy group now encompasses more than 164,000 patients and practitioners who have enlisted to protect and preserve pharmacy compounding! IACP is working to increase this support base to 200,000 members in 2013 to make our voices even stronger! P2C2 brings together people who know first-hand that compounded medicines are a critical part of modern, individualized health care and provides them the necessary tools to ensure that access to personalized medication solutions remains possible.

As part of this effort, IACP designed a new grassroots campaign - My Health. My Compounds - to help our members communicate to your respective patients and practitioners about the immense value of compounding, and the importance of protecting their access to personalized medications. We urge you to feature this artwork on your websites, newsletters, social networking sites, email signatures, printed pieces,etc., as well as share with your patient/practitioner audiences.

Ask your patients and practitioners to add their voices to the S. 959 advocacy site, making their respective representatives aware of the concerns about the draft pharmacy compounding bill. 

ENCOURAGE YOUR PATIENTS TO TAKE ACTION:  Click here to tell Washington how important your customized meds are!

My Health My Compounds Artwork For Member and Patient Use!

Please use this artwork on your websites, newsletters, social networking sites, and as your email signature! 

My Health. My Compounds. Email Signature Artwork

My Health. My Compounds, Website Banner 390x240 px

My Health. My Compounds. Website Banner 500x333 px

My Health. My Compounds. Facebook Cover Artwork 

Pharmacy Compounding Postcard - General

Compounding for Bio-identical Hormone Patients Postcard

Compounding for Veterinary Patients Postcard

Compounding for Pediatric Patients Postcard

Compounding for Geriatric Patients Postcard

Corporate Partner Spotlight: Letco Medical

Since 1993 Letco Medical has been committed to providing compounding pharmacies complete customer satisfaction by offering the highest quality products, customer service, technical support and the fastest delivery time s in the industry. Letco is your partner in compounding. We have an extensive line of chemicals, supplies, equipment, capsules, solutions and bases to support compounding pharmacies. Letco Medical was also the first in our ndustry to offer CSOS ordering for your convenience.

Through a consistent, straightforward formula — high quality products, value-driven service and a commitment to customer success — Letco has helped generations of compounding and specialty pharmacies thrive. In addition to pharmaceutical ingredients, excipients, supplies and equipment, we deliver the insight and responsiveness that customers need to grow and streamline their business.

We pride ourselves on knowing that satisfaction of a job well done is derived through a combination of hard work, perseverance and a thoughtful approach to do our best for our customers and our company. We communicate honestly and openly to continue to build long lasting, trustworthy relationships with our customers and employees. We thank you for trusting us as partners in your compounding pharmacy.

Let us put our expertise to work for you. Quality compounding starts here. 

Please Donate to IACP!

IACP is working to Protect, Promote & Advance Pharmacy Compounding. Please help IACP continue our ongoing legislative, regulatory and press efforts on issues including: S. 959, reimbursement, and preserving patients and practitioners' access to pharmacy compounds. With your help, IACP can continue to play an active role in protecting our profession.

Please click the Donate button above to access an IACP donation form. One-time sums, or monthly contributions are both available for your consideration. We greatly appreciate anything you can do to help support our efforts, and for being an IACP Member! 

We Thank the IACP Members and Corporate Partners Contributing to the Academy!

Click here to view the entire list.  

IACP Welcomes New Corporate Partner!

The IACP Corporate Partner program engages corporate leaders in the pharmacy compounding community by connecting them with IACP’s more than 2,700 pharmacists, technicians, students, and members of the compounding community.  We encourage all IACP members to support these corporate partners that are instrumental in our joint effort to protect and grow this vital part of quality health care. Thank you for your continued support of pharmacy compounding! 

The Educational Conference Goes to Fort Lauderdale, Florida, February 5-8, 2014.

Registration Is Now Open!

Don’t miss this one-of-a-kind, 3-in-1 conference that brings the pharmacy profession together in paradise.  The American College of Apothecaries (ACA), the International Academy of Compounding Pharmacists (IACP) and the American College of Veterinary Pharmacists (ACVP) are joining forces again to bring you an extraordinary Educational Conference, February 5-8, 2014 at the ocean front property, the Harbor Beach Marriott Resort & Spa in Fort Lauderdale, Florida.

What you can expect in 2014:

  • Benefit from multiple education tracks; practice-based, compounding, and veterinary clinical and compounding.  
  • Learn the fundamental steps to successfully work with your local media.
  • Develop a Social Media campaign about your pharmacy and its role in the community.  
  • Leverage the latest tools and resources to implement a quality improvement plan in your pharmacy.
  • Hear what your peers are doing in the This Works for Me! sessions.
  • Tips for hiring and retaining good employees for a successful pharmacy.  
  • What’s New in Veterinary Pharmacy, and much more!
  • Visit with companies showcasing services that can improve your business.

Click here to read more! 

Austin, TX and Houston, TX Regional Education Meeting Recaps!

 The IACP Regional Education Meeting in Austin, Texas on Tuesday, August 6, 2013 hosted 30 pharmacists, technicians, and pharmacy students! The Houston, Texas IACP Regional Education Meeting on Thursday, August 8, 2013 hosted 20 pharmacists, technicians, and pharmacy students!

At both meetings attendees listed to IACP’s Executive Vice President & CEO David G. Miller, RPh as he presented a two-hour dynamic presentation titled, Pharmacy Compounding Law and Regulations: Staying Current in a Changing World.

A big thank you to Peoples Rx Pharmacy for hosting the IACP Regional Education Meeting in Austin! 

Where is IACP’s David G. Miller Headed to Next?

The IACP Regional Education Meeting brings 2.0 contact hours (.20 CEUs) of live pharmacy law continuing education credit to pharmacists and technicians all across the United States. At this seminar, you will hear from IACP's Executive Vice President & CEO David G. Miller, RPh as he presents Pharmacy Compounding Law and Regulations: Staying Current in a Changing World, an in-depth presentation on federal and state legislative and regulatory issues that affect you and your practice.

The seminar is designed for any pharmacist, technician or pharmacy student currently involved in or interested in building their understanding about compounding pharmacy.  Whether you’re a veteran compounder or just thinking about implementing this critical health service for your community, we hope you’ll join us for an evening of education and fellowship. For more information, please visit

At the conclusion of this seminar, the pharmacist and technician attendee will be able to:

  • Explain how compounders are regulated and enforced by the State Boards of Pharmacy, Food and Drug Administration (FDA), and Drug Enforcement Administration (DEA).
  • List four different regulatory initiatives and two court cases that have defined FDA’s oversight to compounders.
  • State what authority the FDA has when inspecting compounding pharmacies.
  • Define “bulk ingredients” and the difference between “FDA-approved” products.
  • Define “office use” and describe how compounding for office use differs from wholesaling.
  • Describe key components of federal proposed legislation that may change the balance of existing federal and state authorities

Salt Lake City, Utah – September 26, 2013
6:30 - 7:30 p.m.     Check-in period with pizza & refreshments
7:30 - 9:30 p.m.     Educational Session
9:30 - 10:00 p.m.   Q&A with David Miller and Department of Professional Licensing’s Compounding Task Force: Kavish Choudary, Christopher Cox, Kort Delost, Missy Duke, Trip Hoffman, Christine Jacobsen, Dean Jolley, Adam Jones, Wayne Jones, Dallas Moore, Jim Ruble, Evan Vickers, Angela Whitney, and Victoria Zippi

Roseman University of Health Sciences, P2 Classroom, 1st Floor
10920 S. River Front Parkway, South Jordan, UT 84095
Click here to view the event flyer for more details!

Tulsa, Oklahoma – November 9, 2013
5:00 - 7:30 p.m.
Hyatt Regency Tulsa, Diplomat Room, 2nd Floor
100 East 2nd Street, Tulsa, OK 74103
Click Here to View the Event Flyer for More Details!



This meeting will correspond with Freedom’s November CPCSI training and the Freedom Pharmaceuticals 2nd Annual Seminar. More information coming soon.

Would You Like to Sponsor or Host an IACP Regional Education Meeting in Your City?

If you would like IACP to plan a Regional Education Meeting in your city, please email Michelle Greene or call 281.933.8400. For more information on sponsorship, please click here. For more information on hosting, please click here.  

IACP Calendar

IACP is your one-stop resource for all things compounding! CompounderCalendar provides a comprehensive listing of compounding events and continuing education programs.

Click here to view IACP’s Upcoming Events. 

IACP Career Center

Welcome to the IACP Career Center!

Your destination for exciting job opportunities and the best resource for qualified candidates within the Industry.

Click here to view the IACP Career Center. 


 Stay connected to IACP by joining our online communities!



In this Section

Share your Knowledge - Become a Preceptor!

IACP Featured in July/August IJPC - Legislative/Regulatory Update

IACP Fax Facts Keeps you Informed! 

Be One Get One Membership Campaign 

Call for Nominations - 2014 IACP Board of Director Elections 

IACP Presents at The Compounders Group Chicago Conference

Share your Knowledge - Become a Preceptor!

Looking to help develop a young mind and expand the learning experience outside of the classroom? Become a preceptor today!

IACP has 1,500 student members who would love an opportunity to roll up their sleeves and learn from the best. Please sign up today at

IACP Featured in the July/August IJPC – Legislative/Regulatory Update

The International Journal of Pharmaceutical Compounding (IJPC) features an IACP Legislative/Regulatory section in each of its issues. The July/August edition highlights IACP’s Compounders on Capitol Hill wrap-up report and stats! Click here to view.

Are you an IJPC subscriber? If not, you’re definitely missing out. IJPC is the only peer-reviewed publication dedicated solely to pharmacy compounding. For more information or to subscribe, please call IJPC at 800-757-4572 or via

IACP is a proud affiliate of IJPC.

IACP Fax Facts Keeps you Informed!

IACP Fax Facts is a weekly fax to help keep you up-to-date on the quickly evolving legislative, state board and regulatory environment. Look for this fax every week, as IACP provides you with the latest news and information important to pharmacy compounding and your practice. Previous Fax Facts issues can be found in the IACP Members Only Site - Communications Tab.

Click here for today's edition of IACP Fax Facts!

Fax Facts is a hit!
We've heard from many members that they enjoy the short, pointed and timely messaging in IACP's Fax Facts! If you did not receive IACP's fax, please email with your current fax number. Please also contact us with any questions on this information!

Be One Get One Membership Campaign: Help Grow IACP this Summer

We know how important a collective voice of compounding is and that NOW is the time to grow that voice. You can help by participating in the IACP Be One Get One Campaign. When it comes to spreading the word about the value of membership, no one does it better than YOU, a current member.

The campaign aims to grow IACP’s membership by recruiting from within our own members’ pharmacies. Ever thought of gifting your staff with a membership? Or encouraging them to join the only association that represents pharmacy compounders in the legislative & regulatory affairs arena? NOW is the time to do it!

This summer IACP is offering a discount for new memberships. Register at least one new staff pharmacist and one new technician and get BOTH first year membership fees for a discounted $300 with our 1+1=300 summer special! Click here for more information.

Click here for more information or to participate in IACP’s Be One Get One Campaign.

Call for Nominations - 2014 IACP Board of Directors Elections

IACP’s nominating process for the 2014 Board of Directors election cycle is now open! The Bylaws of IACP set forth an open election process with nominations for candidates accepted directly from the membership.

Interested candidates may be nominated or may be self-nominated to the IACP Nominating Committee chaired by IACP Immediate Past President Scott Karolchyk, MS, RPh, FIACP. The IACP Board of Directors receives the Nominating Committee report at its October Board Meeting, approves the slate of candidates, and then all qualified IACP members are able to participate in the election process held each November.

This year, there are seven Board of Directors’ seats for which candidates are sought as well nominees for the position of IACP Vice President. Click here for more information.

IACP Presents at The Compounders Group Chicago Conference

In late July, IACP EVP David G. Miller, RPh, made a special presentation to 60 people attending The Compounders Group's second annual seminar in Chicago.

There was a lively discussion on the the implementation of the Affordable Care Act and the associated business opportunities.The Compounders Group is the industry's first and largest buying group, dedicated to growing client pharmacies practices. Visit, and their Facebook page. For more information, please contact Susanne Williams.


Association Management Software Powered by®  ::  Legal